Search Results

Response to Raschi E et al. 'Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction'.

• Authors : Gupta MA; Department of Psychiatry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada.; Vujcic B

Subjects: Hidradenitis Suppurativa*; Adalimumab ; Humans

• Source: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2020 Aug; Vol. 34 (8), pp. e431-e432. Date of Electronic Publication: 2020 AprPublisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System.

• Authors : Fusaroli M; Pharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. .; Polizzi S

• Source: Drug safety [Drug Saf] 2024 Aug 15. Date of Electronic Publication: 2024 Aug 15.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Meta-analyzing Results From Disproportionality Analysis of Individual Case Safety Reports: A Note of Caution.

• Authors : Fusaroli M; Khouri C; Poluzzi E

Subjects: Meta-Analysis as Topic*; Humans ; Adverse Drug Reaction Reporting Systems/Adverse Drug Reaction Reporting Systems/Adverse Drug Reaction Reporting Systems/statistics & numerical data

• Source: Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2024 Jul-Aug 01; Vol. 44 (4), pp. 443-444. Date of Electronic Publication: 2024 Jun 21.Publisher: Williams And Wilkins Country of Publication: United States NLM ID: 8109496 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis.

• Authors : Raschi E; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Via Irnerio 48, 40126, Bologna, Italy. .; Salvo F

Subjects: Pharmacovigilance* ; Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/statistics & numerical data ; Peer Review*

• Source: Drug safety [Drug Saf] 2024 Jul; Vol. 47 (7), pp. 601-605. Date of Electronic Publication: 2024 Mar 18.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals.

• Authors : Lunghi C; Department of Medical and Surgical Sciences, University of Bologna, Via Irnerio 48, 40126, Bologna, Italy. .; Population Health and Optimal Health Practices Research Unit, CHU de Québec-Université Laval Research Centre, Quebec, Quebec, Canada. .

• Source: Drug safety [Drug Saf] 2024 Jul 11. Date of Electronic Publication: 2024 Jul 11.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Suspected adverse reactions to medications and food supplements containing Serenoa repens: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports.

• Authors : Crescioli G; Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmacology and Toxicology, University of Florence, Florence, Italy.; Tuscan Regional Centre of Pharmacovigilance, Florence, Italy.

Subjects: Serenoa*/Serenoa*/Serenoa*/adverse effects ; Prostatic Hyperplasia*/Prostatic Hyperplasia*/Prostatic Hyperplasia*/drug therapy; Male

• Source: Phytotherapy research : PTR [Phytother Res] 2023 Nov; Vol. 37 (11), pp. 5289-5299. Date of Electronic Publication: 2023 Jul 18.Publisher: Wiley Country of Publication: England NLM ID: 8904486 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1573

Record details

Tumor Lysis Syndrome with CD20 Monoclonal Antibodies for Chronic Lymphocytic Leukemia: Signals from the FDA Adverse Event Reporting System.

• Authors : Xia S; Department of Pharmacy, The Second Xiangya Hospital, Central South University, 139# Renmin Middle Road, Furong District, Changsha, 410011, China.; International Research Center for Precision Medicine, Transformative Technology and Software Services, Changsha, 410011, China.

• Source: Clinical drug investigation [Clin Drug Investig] 2023 Oct; Vol. 43 (10), pp. 773-783. Date of Electronic Publication: 2023 Sep 27.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study.

• Authors : Fusaroli M; Pharmacology Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. .; Salvo F

Subjects: Adverse Drug Reaction Reporting Systems* ; Drug-Related Side Effects and Adverse Reactions*; Humans

• Source: Drug safety [Drug Saf] 2023 Sep; Vol. 46 (9), pp. 857-866. Date of Electronic Publication: 2023 Jul 08.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians.

• Authors : Raschi E; Pharmacology Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Via Irnerio 48, 40126, Bologna, Italy. .; Rossi S

Subjects: Antineoplastic Agents, Immunological*/Antineoplastic Agents, Immunological*/Antineoplastic Agents, Immunological*/adverse effects ; Myocarditis*/Myocarditis*/Myocarditis*/chemically induced ; Myocarditis*/Myocarditis*/Myocarditis*/diagnosis

• Source: Drug safety [Drug Saf] 2023 Sep; Vol. 46 (9), pp. 819-833. Date of Electronic Publication: 2023 Jun 21.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality.

• Authors : Schoretsanitis G; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, New York.; Department of Psychiatry, Zucker School of Medicine at Northwell/Hofstra, Hempstead, Glen Oaks, New York.

Subjects: Liraglutide*/Liraglutide*/Liraglutide*/therapeutic use ; Liraglutide*/Liraglutide*/Liraglutide*/adverse effects ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/adverse effects

• Source: JAMA network open [JAMA Netw Open] 2024 Aug 01; Vol. 7 (8), pp. e2423385. Date of Electronic Publication: 2024 Aug 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet

Record details